Infection prevention and control

CHAPTER 16 Infection prevention and control






An overview of the problems with and management of health care associated infection and infectious diseases


Health care associated infection (HCAI), previously known as hospital-acquired infection (HAI) and in some countries as nosocomial infection, is the term used to refer to infection acquired during receipt of some form of health care. This updated terminology more accurately reflects the diverse range of settings in which health care is delivered and where infection may arise. There is ongoing concern and activity in the UK, and globally, in relation both to HCAI and the prevention and control of all infectious diseases.


Infectious agents, including different bacteria and viruses capable of rapid spread within health care environments, cause major disruption and impact significantly on the provision of high-quality health care. Currently, these include Clostridium difficile, influenza, norovirus (known as winter vomiting diarrhoeal disease) and respiratory syncytial virus (RSV, in paediatric wards). The occurrence of antimicrobial-resistant microorganisms, such as meticillin-resistant Staphylococcus aureus (MRSA) and glycopeptide-resistant enterococci (GRE), attributed in part to many years of use and misuse of antimicrobial agents, has also risen over the last two decades, causing significant patient safety concerns in UK health care. Common microorganisms, including Staphylococcus aureus, continue to genetically mutate, developing resistance to antimicrobial agents in order to ensure their survival in a changing environment.


The latest HCAI prevalence surveys in adult patients were conducted in 2006 in acute hospitals across England, Wales, Northern Ireland and the Republic of Ireland (Smyth et al 2008) and in 2005–2006 in both acute and non-acute hospitals in Scotland (Reilly et al 2008). The results estimate the prevalence of HCAI to be between 7.3 and 9.5%, which means that at any one time approximately one in eight patients could have an HCAI. Infections associated with invasive procedures and the use of medical devices such as intravascular devices and urinary catheters account for a high proportion of HCAI. Prevalence and incidence results in the UK also reiterate the fact that common microorganisms like those that have already been mentioned continue to cause problems.


It had been thought that up to one third of all HCAIs would be preventable by better application of proven methods of prevention (Haley et al 1985, Harbarth et al 2003). However, more recently it has been claimed that certain HCAIs, in particular central venous catheter-related bloodstream infections, could potentially be eliminated (Pronovost et al 2006). The nurse has a crucial role in achieving this, as described in this chapter.


Emerging infections such as Legionnaire’s disease, human immunodeficiency virus (HIV), severe acute respiratory syndrome (SARS) and pandemic influenza also continually pose challenges to public health as well as to health care settings. This necessitates contingency planning both at population level and within organisations, including health care systems. For example, during the 2009 influenza A (H1N1), or ‘swine flu’ pandemic, the extensive planning that had taken place across many parts of the world and within health care systems in the preceding years enabled a rapid response to the situation as it evolved over time. The tremendous increase in world travel over recent years has added to concerns about the threat posed by infectious diseases, many of which can spread rapidly around the world affecting large numbers of people. Whilst in the UK, the long-standing, vaccine-preventable infectious diseases including measles, mumps and rubella (MMR) affect only a small number of people compared to the past, reduced uptake of childhood immunisations such as the MMR vaccine has in recent years resulted in lowered ‘herd’ immunity (immunity across an entire population) and, consequently, an increase in these diseases. Infections familiar only to older generations, for example smallpox, have caused recent concern in an age when there is heightened awareness of the risks from bioterrorism. Governments internationally are preparing both for the re-emergence of diseases that have previously been eradicated or controlled and for the emergence of new diseases, at the same time as attempting to control the common HCAIs occurring in our health care settings.


Less common in the UK, but often with drastic outcomes, are infections spread via the food-borne route. In the past these have had a major impact on both hospital settings and the community. The outbreak of Escherichia coli O157 infection, spread through meat in a butcher’s shop in Wishaw, Lanarkshire, in 1996, resulted in the death of many people within that community and attracted much media interest over hygiene controls in food premises. In hospitals and care facilities, guidance on effective food preparation, production and distribution techniques is vital for effective infection control. The nurse’s role in food hygiene often involves basic measures such as ensuring patients’ own food is in date, stored and reheated correctly. It may also include maintaining correct hygiene procedures relating to enteral feeding systems. Awareness of the importance of food hygiene overall is essential.


Infection prevention and control measures aim to reduce the burden of HCAI and other infectious or communicable diseases, on individuals, health care organisations, and within the National Health Service as a whole. The Health Protection Agency, Health Protection Scotland and Departments of Health in all UK countries coordinate many activities, such as national surveillance and control programmes, in order to highlight and act upon the actual burden in specific settings (see Useful websites, p. 515). Nurses are well placed to contribute to the prevention, control and management of infection within health care settings and beyond. Indeed, nurses occupy a wide diversity of roles, including those concerned with public health, providing ever-increasing opportunities to influence the health protection and patient safety agendas.


For further information about the national burden of HCAI and spread of other infectious diseases, see the recent national prevalence surveys (Reilly et al 2008, Smyth et al 2008), National Audit Office reports (2000, 2004, 2009), the Care Quality Commission’s work, the UK Health Department websites, the Health Protection Agency and Health Protection Scotland websites (see Useful websites, p. 516).



How infection spreads


The terms ‘infection process’, ‘cycle of infection’ and ‘chain of infection’ are often used to describe the circumstances that can lead to patients or others developing an HCAI or any infectious disease. The rationale for applying infection prevention measures is based on this chain of events. It is crucial to understand how microorganisms spread and infection occurs. The infection process involves:









The principles relating to all infection prevention measures are based on the interruption of this process. If these measures are not taken, a cycle will continue whereby patients, and possibly staff and others, may be exposed to potentially pathogenic (disease-causing) microorganisms that can cause harm.



Microbiology


Microbiology is the study of microorganisms and other causes of infection, including bacteria, viruses, fungi, protozoa, prions and helminths.









Routes of transmission


Clear understanding of the most common routes or means of transmission of microorganisms can ensure that appropriate precautions are taken to minimise the risk of spread of infection in all situations.








Certain organisms can be transmitted through more than one of these routes and all modes of spread must be considered when carrying out risk assessments and providing safe care.



The infection prevention team


Health care workers, patients, relatives and carers together have a contribution to make in the prevention, control and management of the spread of infection. Those involved include nurses, doctors and dentists, allied health professionals, microbiology laboratory scientists, health care assistants, domestic and catering services, estates management, sterile services staff, administrative and management staff, education and training staff.


The role of the infection prevention team (IPT) has been defined and includes the utilisation of the risk management approach (see p. 505), provision of relevant specialist advice, ensuring appropriate measures and action plans are in place and supporting sustained improvement through a change of culture throughout their health care organisation. The team has clear accountability for reporting infection prevention and control progress and issues through relevant management structures, such as clinical governance and patient safety committees and, at times, directly to chief executives. The infection prevention doctor (IPD) and infection prevention nurse (IPN) have clear responsibilities within the health care organisation. More recently, leadership and management roles, including the Nurse Consultant, Director of Infection Prevention and Control (in England and Wales) and Infection Control Manager (in Scotland) have added to the structure.


Other recent additions to the IPT include audit and surveillance staff amongst other invaluable support staff. Whilst in secondary care settings this arrangement is generally well established, this is not always so within primary care, where the community-based IPT may be a relatively new addition, yet provide a vital service, both for commissioning and provision of specialist services. The role of the health protection nurse working at regional or national level may also be a relatively new contact for infection prevention and control teams, but provides an important link as part of the strategic infection prevention work within a locality and nationally.


Many settings also have infection prevention link personnel to enhance the effectiveness of the work of the team. The link person in a ward, department or community team receives additional education to improve the communication between infection prevention and control teams and the clinical setting and may assist with clinical audit and awareness of clinical staff in relation to Standard Precautions (see p. 507).


The work of the infection prevention team is guided by the Control of Infection Committee, which is responsible for strategic and operational decisions about infection prevention and control within a given organisation or, in the case of the community, across a locality. However, the IPT also reports to clinical governance, risk management and patient safety committees to ensure action and effective cross-facility outcomes. The outcomes for infection prevention programmes of work at organisation level, as led by teams, are guided by national and local requirements and needs.



The nurse’s role in infection prevention


Nurses can contribute to all aspects of infection prevention in clinical practice, acting as role models and educating others. Nurses have a pivotal role in managing infection in acute and primary care settings by:









Nurses in the UK have a duty of care as stated in the Health and Safety at Work Act (1974) to prevent, control and manage infection. Nurses, as the largest staff group in health care, have a responsibility to deliver care based on the best available evidence or best practice (Nursing and Midwifery Council [NMC] 2008). This includes preventing the spread of infection, ensuring they do not put themselves and others at unnecessary risk from infection. In England and Wales, The Health and Social Care Act (DH 2008, p. 2) requires health care professionals to ‘demonstrate good infection control and hygiene practice’.


Nursing assessment is vital to health and infection prevention, whether the health care setting is the home, the hospital, the clinic or the care home, as it can reveal crucial information about patients, their surroundings and their behaviours. Nursing models and processes must incorporate approaches to prevention, control and management of infection, for example, within care plans and pathways.


The health of nurses while at work is also important. Nurses should:







Diagnostic sampling


The collection of specimens for microbiological examination is an important element of a nurse’s role. It enables identification of microorganisms to aid diagnosis and ensure appropriate treatment. In the case of bacterial infection, accurate diagnosis enables the use of narrow-spectrum rather than broad-spectrum antimicrobial agents, which optimises treatment and reduces problems associated with antimicrobial use. A sample may also be taken for screening purposes, e.g. to exclude previous known infections or as part of contact tracing. The UK countries currently have a range of policies on screening for antimicrobial-resistant organisms and, in particular, MRSA (see Useful websites p. 516).


Samples may be taken from various sources according to the person’s presenting symptoms or, in the case of screening, the most likely sites of colonisation. These include swabs from sites such as the ear, nose, throat, eye, vagina, skin or wound. A fluid specimen or, in some instances, a sample of tissue, may be taken from the respiratory tract (e.g. nasopharyngeal aspirate, sputum), the gastrointestinal tract and biliary system (e.g. faeces), the genitourinary tract (e.g. urine) and the circulatory system (e.g. blood). Samples of vomit are not normally sent for testing as the results are of limited analytical value. In order to avoid false positive and false negative results, it is important to ensure that there is no contamination from other microorganisms while obtaining samples, that an adequate amount of a sample is taken and that it is sent promptly to the laboratory or stored appropriately until it is sent. The storage requirement for different samples varies, so it is important to ensure the correct procedure is followed. For example, a sputum specimen must be sent to the laboratory immediately, as respiratory pathogens do not survive for long periods. Although urine ideally should be examined in the laboratory within 2 hours, it can be stored in a specimen fridge for up to 24 hours to prevent bacteria multiplying and giving misleading results. Likewise, a wound or MRSA swab can be stored overnight in a specimen fridge. Blood cultures differ, as they must be sent to the laboratory immediately or stored at room temperature, but must not be refrigerated.


The value of swab sampling is frequently questioned, but it is a common, convenient and inexpensive option in clinical practice. If contamination occurs, for example, from intact skin surrounding a suspected infected surgical wound (false positive), or not enough sample is sent to the laboratory, for example a dry swab is used to sample a small patch of dry skin for microbiological screening purposes (false negative), analysis will be limited and results will not be meaningful. Accurate completion of laboratory forms is also essential to provide laboratory staff with the information needed to select appropriate diagnostic tests. Whilst demographic information about the patient is often computer generated nowadays, relevant information about the patient’s condition, current medication or treatments (e.g. antibiotics), the source of the specimen and its purpose (e.g. screening or confirming the diagnosis of infection) is important to include.



Epidemiology


Epidemiology is the study of disease in relation to populations, e.g. who is being affected by MRSA or influenza, and when and where they are being affected. Epidemiological data are crucial in guiding actions and therefore all staff should support and become involved in collecting data and taking on board feedback in order to enhance targeted patient care and treatment. A population considered at risk, for example from Clostridium difficile, could be monitored using epidemiological methods to gather information which relates the disease to the population by studying both ill and healthy individuals. Epidemiology is closely linked with risk assessment and management. Results of epidemiological monitoring help to affect outcomes, for example reductions in infection rates by influencing infection prevention and control measures featured in, for example, action plans and care plans.


In order to identify infectious diseases including HCAI, methods must be in place to gather the appropriate information to inform knowledge of the distribution of such diseases. There are various ways to monitor disease.





Data collected over time show the changing patterns of infectious diseases in our society, providing information about newly emerging diseases and identifying specific problem areas, e.g. outbreaks and seasonality of diseases. This informs the risk management process, which contributes to the prevention of infections and the control of outbreaks of infection.


Mandatory surveillance systems are in place throughout the UK and tools are provided to support the collection and collation of data. It is important that principles, including definitions, for epidemiological monitoring are followed to allow for reliable and comparable data in order to show improvement or deterioration over time.



The risk management approach


The risk to health from infection is one of many risks to be managed in health care settings. The risk management approach to HCAI was developed during the 1970s as part of the growing health and safety agenda around the developed world. The World Health Organization (WHO 2008) definitions provide a basis for the risk management approach in relation to infection prevention and control:




Hazards and risks from microorganisms are present in our environment at all times. Once they are identified, appropriate control measures and action plans must be adopted to ensure that the greatest time and resource is spent in the areas with the greatest risks of infection. For example, the approach to the management of MRSA within the health care environment varies according to the risk to patients. In the hospital environment and, in particular, wards and units where patients are deemed to be at high risk of infection with MRSA, such as intensive care units and orthopaedic surgical wards, a more stringent approach to screening, decolonisation treatment and the isolation of patients colonised or infected with MRSA may be taken, as compared with community settings such as care homes and the patient’s own home (Box 16.1). As hazards and risks may change over time, up-to-date guidance on infection prevention and control measures is required for the health and safety of patients and staff.



Box 16.1 Reflection



Mr Brown’s journey


The following scenario concerns an infectious condition that is commonly encountered, both in community and hospital settings. From the information provided, consider: (i) Mr Brown’s susceptibility to infection before admission to hospital; (ii) how Mr Brown’s susceptibility to infection will be affected by his hospital admission and need for surgery; (iii) the ways in which infection risks can be minimised both to Mr Brown and other patients on the ward.


Mr Brown is due to be admitted to hospital for total hip replacement surgery. He is assessed in the outpatients’ clinic 2 weeks before his operation is due. He is 62 years old with type 2 diabetes, treated by hypoglycaemics. On assessment, the significant factors noted are: he is overweight and is a smoker, he states that he eats well and controls his diabetes, his skin is dry in places and he is a social drinker.


His wife is with him and is recovering from a hysterectomy, for which she was discharged from hospital 4 weeks ago. It later transpires that she is continuing to see the practice nurse for an ongoing postoperative wound problem.


Mr Brown is found to have a foot ulcer. During examination of the foot ulcer, signs and symptoms of infection are present, i.e. erythema (redness), swelling and heat, with evidence of scanty serous exudate. Samples are taken and sent to the microbiology laboratory. Also, a nose swab is taken to screen for MRSA. The multidisciplinary team are eager to manage and treat the ulcer appropriately in order to progress with Mr Brown’s proposed hip surgery and are considering antibiotic therapy on results of the samples taken.


The results from Mr Brown’s MRSA screen and foot ulcer yielded MRSA.


Only gold members can continue reading. Log In or Register to continue

Stay updated, free articles. Join our Telegram channel

Oct 19, 2016 | Posted by in NURSING | Comments Off on Infection prevention and control

Full access? Get Clinical Tree

Get Clinical Tree app for offline access